Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Antonio Palumbo
Observed names:
PALUMBO, Antonio,
Palumbo, Antonio
Institution:
GlaxoSmithKline (Switzerland)
Observed institutions:
Roswell Park Comprehensive Cancer Center,
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
GlaxoSmithKline (Switzerland),
University of Turin,
University of Nebraska Medical Center,
Sapienza University of Rome
show all 6
OpenAlex ID:
A5082545947
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis
2017
·
Philip L. McCarthy
, Sarah A. Holstein
, et al.
·
Journal of Clinical Oncology
·
696
PDF
Upfront autologous stem cell transplantation (ASCT) versus novel agent-based therapy for multiple myeloma (MM): A randomized phase 3 study of the European Myeloma Network (EMN02/HO95 MM trial).
2016
·
Michele Cavo
, Antonio Palumbo
, et al.
·
Journal of Clinical Oncology
·
65
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
2022
·
Meletios A Dimopoulos
, Paul G Richardson
, et al.
·
The Lancet Haematology
·
47
Multiple myeloma refractory to lenalidomide: A systematic literature review of trials and real‐world evidence
2024
·
Monique A. Hartley‐Brown
, Katja Weisel
, et al.
·
British Journal of Haematology
·
16
A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) Versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis
2014
·
Efstathios Kastritis
, Xavier Leleu
, et al.
·
Blood
·
11
Phase III randomized controlled study of daratumumab, bortezomib, and dexamethasone (DVd) versus bortezomib and dexamethasone (Vd) in patients (pts) with relapsed or refractory multiple myeloma (RRMM): CASTOR study.
2016
·
Antonio Palumbo
, Asher Alban Akmal Chanan-Khan
, et al.
·
Journal of Clinical Oncology
·
5
Minimal Residual Disease Monitoring During Maintenance In Multiple Myeloma Patients
2013
·
Alberto Rocci
, Manuela Gambella
, et al.
·
Blood
·
3
Improved Igh-Based MRD Detection By Using Droplet Digital PCR: a Comparison With Real Time Quantitative PCR In MCL and MM
2013
·
Daniela Drandi
, Lenka Kubiczkovà
, et al.
·
Blood
·
2
Impact of Treatment Intensification According to Patient Prognosis: A Pooled Analysis of 3 Randomized Phase III Trials
2016
·
Francesca Gay
, Mattia D'Agostino
, et al.
·
Blood
·
1
Dose Escalation Phase 2 Trial of Carfilzomib Combined with Thalidomide and Low-Dose Dexamethason in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma. a Trial of the European Myeloma Network
2014
·
Pieter Sonneveld
, Emilie Asselbergs
, et al.
·
Blood
·
1
Prognostic Implication of Somatic Mutations By Next Generation Sequencing: An Analysis from the Mmrf Commpass Study in Newly Diagnosed Multiple Myeloma Patients
2016
·
Mattia D'Agostino
, Stefania Oliva
, et al.
·
Blood
Dedifferentiation , maldifferentiation or arrested differentiation in human acute myelogenous leukemia.
1983
·
PAGLIARDI, Giovanni Luca
, PALUMBO, Antonio
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Amplified C lambda and c-abl genes are on the same marker chromosome in K562 leukemia cells.
1983
·
Selden JR
, Emanuel BS
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Show more works
View as search
Works count:
16
Citation count:
847
H-index:
5
I10-index:
5
Year
Topic
Type
